Physician profile
Terry Yeung
NPI 1902123698
$39,044.53
in general payments reported to CMS, 2019-2025
14 companies · $851 in 2025
The $851 reported for 2025 was more than what 76% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $3,578 · 2021: $6,576 · 2022: $5,975 · 2023: $2,916 · 2024: $110 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,700 · Travel and Lodging: $639 · Food and Beverage: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,700.00 |
| Travel and Lodging | $639.49 |
| Food and Beverage | $537.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $35,992.80 | 2019-2023 | |
| Stryker Corporation | $2,539.67 | 2019-2025 | Scopis Ent, Clarifix |
| Abbott Laboratories | $183.63 | 2022 | |
| Medtronic, INC. | $96.25 | 2024-2025 | Propel, Nuvent |
| Acclarent, INC | $37.88 | 2019 | |
| Aerin Medical INC. | $32.75 | 2025 | |
| Intersect Ent, INC. | $32.32 | 2019-2020 | |
| Integra Lifesciences Corporation | $29.52 | 2024 | Inspira Air, Acclarent Aera, Trudi Probe |
| Sanofi-Aventis U.S. LLC | $22.22 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $18.94 | 2022 | |
| Glaxosmithkline, LLC. | $16.02 | 2021 | |
| Smith+Nephew, INC. | $15.18 | 2020 | |
| Janssen Pharmaceuticals, INC | $14.72 | 2020 | |
| Olympus America INC. | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Yeung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.